WIXOM, Mich., Oct. 28, 2011 (GLOBE NEWSWIRE) -- Rockwell Medical (Nasdaq:RMTI), a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD) and iron deficiency anemia, announced today that it will hold an investor conference call on Thursday, November 3rd, 2011 at 8:30 a.m. ET to discuss its third quarter 2011 results. Robert Chioini, Chairman and CEO, and Thomas Klema, CFO, will be hosting the call to review Rockwell’s results. Rockwell will be releasing the earnings results on the same date.
